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Accepted 29 May 2013AbstractObjective: To assess the effect of metalloestrogen cadmium (Cd) on the proliferation of endometrial stromal cells (ESC) isolated from the
eutopic endometrium of women with endometriosis
Materials and Methods: ESC were isolated from eutopic endometrial samples from 10 women with endometriosis and 10 women without
endometriosis. ESC cultures were established and maintained in RPMI medium. Cultures were treated with Cd at a concentration of 106 M and
after 24 hours and 48 hours, cell number was counted using the Neubauer hemocytometer to calculate the relative cell proliferation. At 48 hours,
the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay was used to test the effect of different concentrations (108 M to
103 M) of Cd on ESC cultures. Relative cell proliferation and MTT assay results were analyzed with ANOVA.
Results: At 48 hours, Cd-induced ESC proliferation was higher ( p ¼ 0.02) in women with endometriosis than in women without endometriosis,
which was confirmed by the MTT assay.
Conclusion: The results of this study demonstrate the ability of metalloestrogen Cd to induce the proliferation of stromal cells derived from the
eutopic endometrium of women with endometriosis.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Cadmium (Cd) is a heavy metal ubiquitously distributed in
the biosphere largely due to anthropogenic activity [1].
Numerous adverse health effects in humans secondary to Cd
toxicity have been described in the literature [2], which
include carcinogenesis [3]. Elevated levels of Cd in blood [4]
or urine [5] have been associated with an augmented risk of
breast cancer, while long term dietary Cd intake is known to
increase the incidence of postmenopausal endometrial cancer
[6]. Both breast and endometrial cancer are estrogen-* Corresponding author. Department of Physiology, Faculty of Medical
Sciences, University of Sri Jayewardenepura, Gangodawila, Nugegoda, Sri
Lanka.
E-mail address: yasanga@sjp.ac.lk (N. Silva).
1028-4559/$ - see front matter Copyright  2013, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2013.10.015dependent gynecological cancers, which prompted scientists
to further investigate the possible estrogenic properties of Cd
in order to supplement the knowledge that Cd mediates the
malignant transformation of normal breast tissue [7] via
several mechanisms [8].
Identification of the ability of Cd to bind and activate the
estrogen receptor (ER), has defined a group of xenoestrogens,
termed metalloestrogens [9,10], resulting in a paradigm shift
with regards to estrogen-dependent diseases. As a conse-
quence, metalloestrogen Cd has been linked with the etiopa-
thology of estrogen-dependent benign gynecological diseases,
such as uterine myomas [11] and endometriosis [12].
The estrogenic effects of Cd have mostly been demon-
strated in breast cancer cell lines where researchers have
established that Cd stimulates proliferation of cells [13] by
activating either endogenously or exogenously expressed ERscs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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metalloestrogenic effects of Cd in relation to estrogen-
dependent gynecological diseases, including endometriosis.
Hitherto published in vitro effects of Cd using endometrial
cells are confined to few reports, which include that of Tsut-
sumi et al and the report by Helmestam and coworkers. While
Tsutsumi et al describe that Cd causes early induction of
decidualization in endometrial stromal cells (ESC) [15], Hel-
mestam and coworkers have published on the Cd-induced
expression of mRNA for angiogenic genes in cultured endo-
metrial endothelial cells [16].
Recently, the presence of Cd in ectopic endometrial tissue
has been demonstrated [17]. In the absence of any published
reports on the effect of Cd on endometrial cells in respect to
endometriosis, we faced a dilemma in interpreting the sig-
nificance the above finding. This study was conducted as a
preliminary step to assess the effect/s of metalloestrogen Cd
on the proliferation of stromal cells isolated from the eutopic
endometrium of women with endometriosis.
Materials and methodsStudy participantsStudy participants were recruited from women who un-
derwent elective laparoscopy or laparotomy at the Professo-
rial Gynaecology Unit of National Hospital of Sri Lanka,
during the period of April 2011 to March 2012. All recruited
women were in the reproductive age group and did not
receive any hormonal therapy for at least 3 months before the
surgery. Indications for surgery in women without endome-
triosis were investigation of primary or secondary subfertility
or ovarian cyst/s on ultrasonography. Ten women with
endometriosis and 10 women without endometriosis vol-
unteered for this study.
Preoperatively, participants were given details regarding the
nature of the study. The date of the last regular menstrual
period was noted to determine the stage of the menstrual cycle
in each participant. The presence or absence of endometriosis
in each participant was confirmed at the time of laparoscopy or
laparotomy. In women with endometriosis, the disease was
staged from I to IV according to the revised American Society
for Reproductive Medicine (rASRM) classification of
endometriosis.
Using a consent form, written consent was obtained from
all the participants. The protocol mentioned above is in
concordance with the guidelines provided by the Human Tis-
sue Act of 2004 in United Kingdom [18] and the study was
approved by the Ethical Review Committee of the Faculty of
Medical Sciences, University of Sri Jayewardenepura, Sri
Lanka.Collection of eutopic endometrial tissue samplesEutopic endometrial tissue samples were obtained
from participants using the MegGyn endometrial sampler
(Ref No: 022720, MedGyn Products, Inc., USA). Tissuesampling was always performed before methylene blue dye
insufflation, when the latter was performed to ascertain the
tubal patency.
The collected tissue fragments were immediately trans-
ferred into 1.5 mL sterile micro centrifuge tubes containing
1 mL of Hank’s balanced saline solution (HBSS, HyClone
Laboratories, Inc., USA) and within 30 minutes of collection,
tissue samples were transported from the operating theatre to
the cell culture laboratory in HBSS on ice.ESCESC were isolated and cultured as per procedures adopted
from Mathews et al [19] and Finas et al [20], with appropriate
modifications and optimization.
The tissue fragments were placed in Petri dishes (TPP,
Switzerland) and covered with 0.3% collagenase type I solu-
tion (Sigma, USA). Tissue fragments were then minced into
smaller pieces and incubated in 0.3% collagenase for 120
minutes at 37C with intermittent agitation. Collagenase
digestion was terminated by adding an equal volume (10 mL)
of fresh HBSS.
Following collagenase digestion, the solution was passed
through a 40 mm cell strainer (BD Falcon, BD Biosciences,
USA) and the filtrate was collected into two 15 mL centrifuge
tubes (Biologix, USA) and centrifuged at 200 g relative cen-
trifugal force (rcf), for 15 minutes. The resultant cell pellets
were resuspended in 5 mL of RPMI 1640 cell culture medium
(RPMI 1640; Sigma, USA) supplemented with 10% v/v fetal
bovine serum (FBS; Sigma, USA) and 1% v/v antibiotic-
antimycotic solution (Gibco, Invitrogen corporation, UK)
containing 10,000 units/mL penicillin G sodium, 10,000 mg/
mL streptomycin sulfate, and 25 mg/mL amphotericin B in
0.85% saline. Each cell pellet was dispersed and a homoge-
nous cell suspension was prepared using a 1 mL disposable
plastic transfer pipette (Biologix, USA). Aliquots of the cell
suspension were used to estimate the cell number using a
Neubauer hemocytometer (area 0.0025 mm2, depth 0.1 mm,
Thoma, USA) and cell viability with trypan blue dye (Sigma,
USA) exclusion. Once cell number and viability were deter-
mined, the ESC were seeded into a 25 cm2 cell culture flask
with vented cap (Nunc, USA) at a density of 2.5  105 cells
per flask in 5 mL of RPMI medium supplemented with 10% v/
v FBS and 1% v/v antibiotic-antimycotic solution. Cell culture
flasks were then placed in the carbon dioxide incubator (Mini
Galaxi A, RS Biotech, UK) at 37C with 5% CO2 and 95% air/
humidity.
For the purpose of propagation, until the third subculture
(or passage), the cells were grown in either 25 cm2 or 75 cm2
cell culture flasks (Greiner Bio One, Germany). After the third
subculture, for the relative cell proliferation experiments, cells
were seeded into 24-well cell culture cluster plates (Corning,
USA) at a density of 2  104 cells per well. For the 3-(4,5-
dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT)
assay, 5  103 cells per well were seeded into a 96-well cell
culture plate (TPP, Switzerland).
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USA; cat no: 202908) a kind donation by the Atomic Energy
Authority of Sri Lanka, was used to prepare 2  102 M of
cadmium solution. This was then serially diluted using RPMI
medium without FBS to obtain a series of solutions ranging
from 2  103 M to 2  107 M.
-For the relative cell proliferation experiments, cells grown
in 24-well cell culture plates (Corning, USA) at a density of
2  104 cells per well were treated with Cd solution in the
following manner. Medium was first removed in each well and
replaced with 475 mL of RPMI medium with 10% v/v heat
inactivated FCS (Sigma, USA) and 1% v/v antibiotic-
antimycotic solution. Then, 25 mL from a 2  105 M Cd
solution was applied into each well, which gave a final Cd
concentration of 106 M in a 500 mL volume.
During the MTT assay, 10 mL each of different Cd con-
centrations were applied to each well, giving a final volume of
200 mL of RPMI medium supplemented with heat inactivated
FBS. This gave concentrations of 103 M to 108 M of cad-
mium in each well.Determination of relative cell proliferationRelative cell proliferation was assessed using a method
described by Sampey et al [21] with necessary modifications.
After 24 hours and 48 hours of metal treatment, the mono-
layers in 24-well cell culture plates were first washed three
times with 1 mL of HBSS. Then the cells were subjected to
trypsinization with 500 mL of 0.05% trypsin in 0.02% of
EDTA (Sigma, USA) for 15 minutes at 37C. Once all the
cells were detached, trypsinization was terminated with an
equal volume (500 mL) of RPMI medium without FBS and a
cell suspension (1 mL) was obtained by careful mixing of theFig. 1. Relative proliferation of endometrial stromal cells from women without e
treatment of 106 M Cd.contents in each well with a 1000 mL pipette tip (Nichiryo,
Japan) attached to a micropipette (Nichiryo, Japan).
An aliquot of the above cell suspension was used to count
the number of viable cells. After adding 1% w/v Trypan blue,
the cells were loaded into the hemocytometer and the number
of viable cells was determined for 1 mL of cell suspension.
The relative cell proliferation was calculated by dividing the
number of viable cells in each treatment well by that of the
untreated well (control).MTT assayThe effect on overall cell activity was determined by per-
forming the MTT assay [22] on cell monolayers following 48
hours of treatment with Cd. MTT solution (20 mL) was added
to the 200 mL medium in each well of the 96-well plate, and
the plate was incubated at 37C for 4 hours. After removing
the medium and adding 100 mL of 0.04 N HCl in isopropanol
per well, the plate was shaken using the mini orbital shaker for
30 minutes and the absorbance read at 620 nm using a
microplate reader (ELx 800 universal microplate reader, Bio-
tek instruments, USA). Results were expressed as a percent-
age of the control value.
ResultsCharacteristics of the study participantsIn both groups, the eutopic endometrial tissue samples were
obtained during the proliferative phase of the menstrual cycle
from Day 3 to Day 7. While the majority of women with
endometriosis (n ¼ 5) belonged to the Stage III in the rASRM
classification, four women belonged to the Stage IV and one
participant was in Stage II. None of the women who partici-
pated in the study were current smokers.ndometriosis and women with endometriosis after 24 hours and 48 hours of
Fig. 2. Results of MTT assay following 48 hours of incubation with different concentrations of Cd (108 M to 106 M).
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increased in response to treatment with 106 M Cd. This in-
crease reached statistically significant levels ( p ¼ 0.02; two
way ANOVA) at 48 hours of incubation when compared to the
relative proliferation of ESC in women without endometriosis.
(Fig. 1)MTT assayWhen treated with Cd concentrations of 107 M and
106 M, the MTT results were significantly higher ( p < 0.05)
in women with endometriosis, when compared with the same
values from women without endometriosis (Fig. 2). Similar
mean MTT results were observed in both groups in respect to
other Cd concentrations that were tested. There was no clear
dose response relationship in either group in respect to any of
the Cd concentrations.
Discussion
In this study, the effects of Cd on cultured ESC were
investigated, where a comparison was made between the
cultures from women with and without endometriosis. Cell
proliferation in response to Cd treatment was assessed by
means of relative cell proliferation experiments and the MTT
assay. In the relative cell proliferation experiments, significantdifferences were noted in cultures that originated from women
with endometriosis following 48 hours of Cd treatment. When
the MTT assay was performed using ESC incubated with
different concentrations of Cd for 48 hours, there were dif-
ferences in MTT results only in the endometriosis group in
respect to 107 M and 106 M of Cd, with no clear dos-
eeresponse relationship.
In the present study, the method of direct counting of viable
cells using a hemocytometer was adopted to calculate the
relative proliferation after assessing stromal cell viability by
Trypan blue dye exclusion. These experiments were based on
a protocol described by Sampey et al who tested the effects of
phytoestrogen genistein on cultured ESC [21]. Direct counting
of stromal cells has been employed by Gazvani et al and
Klemmt et al as a measure of stromal cell proliferation
[23,24]. The latter research group used a Neubauer hemocy-
tometer for counting viable stromal cells following trypan blue
exclusion.
However, direct counting of cells to derive a measure of
cell proliferation is considered by some as a subjective method
[25]. Thus, different concentrations of Cd were used in the
MTT assay to confirm the stimulation of stromal cell prolif-
eration. The MTT assay is considered as a good indicator of
viable and glycolytically active cells [22]. It is noteworthy that
many authors, including Chang and coworkers who probed the
effect of arsenic on primary ESC cultures [26], have used the
MTT assay to assess the proliferation of stromal cells. Hel-
mestam and colleagues opted to use the WST-1 assay to gauge
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cadmium chloride [16]. The WST-1 assay is an improved
version of the MTT assay where a tetrazolium dye is used to
detect cell viability [25].
Published literature on the effects of cadmium on ESC is
confined to two studies conducted by Tsutsumi et al and
Kawano and colleagues. While the former group investigated
the effect of Cd on the decidualization of ESC following Cd
treatment, the latter evaluated the metallothionein levels due to
Cd exposure. Neither group report on the proliferation of ESC
subsequent to administration of Cd. According to the results of
Tsutsumi et al, the most effective dose of Cd was 1 mmol/L
[15], while Kawano et al noted the highest metallothionein
expression in ESC at a concentration of 10 mM of cadmium
[27]. In the present study, a Cd concentration of 106 M was
able to enhance the proliferation of ESC from women with
endometriosis after 48 hours, which is similar to the dose of
Cd described by Tsutsumi and coworkers. However Tsutsumi
et al incubated the ESC for 12 days, to elicit the effects of Cd
at the said concentration. Induction of metallothionein is an
indicator of toxicity of Cd on cells that occurs at higher doses
of the metal [28]. Therefore, a Cd concentration greater than
105 M appears to be toxic to cultured ESC as observed in the
present study where the cell viability decreased in doses above
105 M (Fig. 2).
The growth stimulatory effects of metals on estrogen sen-
sitive cells are largely confined to the experiments conducted
on breast cancer cell lines such as MCF-7, TD47, and SKBR3.
Both Garcia-Morales et al and Choea et al report on the sig-
nificant proliferative effects of Cd on MCF-7 cells at a dose of
106 M following a 24 hour incubation [13, 29]. The latter
group was able to elicit a dose-dependent response of MCF-7
cell growth due to Cd treatment, where the EC50 was calcu-
lated as 1.08  107 M. After incubating for 24 hours at a Cd
concentration of 50e500 nM, Yu et al were able to demon-
strate the proliferation of SKBR3 breast cancer cells [30]. In
the present study, a significant proliferation of ESC was
observed in the endometriosis group after the administration of
106 M cadmium for 48 hours. Although the concentration of
Cd is comparable to previous experiments conducted on MCF-
7 cells, the incubation time differs with a longer time period
being required to observe the growth stimulatory effects of Cd
of ESC. The MCF-7 cell line is derived from malignant breast
cancer tissue with a faster growth rate that has a shorter
doubling time [31], while in comparison, the ESC are noted to
have slow growth rates [19]. It is probable that the mitogenic
effects of Cd attenuate the innate growth potential of the es-
trogen responsive cells in vitro. Nonetheless, negative results
in respect to the stimulation of MCF-7 cell proliferation
following Cd treatment at a dose of 107 M have been re-
ported [32].
A dose-dependent response for Cd could not be observed in
this study, contrary to findings of previous researchers on
MCF-7 cell lines. Neither Tsutsumi et al nor Kawano et al
have reported any dose-dependent effects of Cd in their studies
involving cultured ESC, raising the possibility of Cd-induced
responses on cultured endometrial cells being devoid of adose-dependent relationship. This inference is further
strengthened considering the results of Helmestam and co-
workers who reported on the lack of a dose-dependent
response after exposing endometrial endothelial cells to
different concentrations of cadmium chloride, where the
expression of VEGF-A was measured [16].
Taken together, the findings of this study indicate the ability
of Cd to induce proliferation of ESC, which was prominently
observed in women with endometriosis. Cadmium probably
induced these effects in ESC from women with endometriosis
by acting through the ER. The lack of similar effects in women
without endometriosis is perhaps partly attributable to the
differences in the ER levels in the eutopic endometria of the
two groups, where higher numbers of ERs are expressed in
women with endometriosis [33,34]. However, confirmation of
the above requires the demonstration that an antiestrogen such
as fulvestrant will abrogate the observed changes secondary to
Cd treatment in ESC from women with endometriosis. In
addition, increased Cd deposition, initially in ESC of women
with endometriosis, is another possibility that has to be
entertained in interpreting the findings of this study. Ideally,
the levels of Cd in the ESC monolayers should have been
measured before Cd treatment in the present study. Lack of
such data, a limitation of the present study, was due to the fact
that the detection limits of the available instruments were
insufficient to measure minute amounts of Cd that may have
been present in the cell culture samples.
In conclusion, the results of this study demonstrate the
ability of Cd to induce the proliferation of stromal cells
derived from the eutopic endometrium of women with endo-
metriosis. As women are susceptible to ill effects of Cd due to
widespread environmental pollution, further research is rec-
ommended to shed more light on the role of Cd on estrogen-
dependent gynecological diseases, especially endometriosis.Acknowledgments
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